← FDA Drug Approvals (Drugs@FDA)
MIDODRINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVUGEN · Approved 2023-10-17
Drug application
- FDA Application #
ANDA211973- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MIDODRINE HYDROCHLORIDE
- Generic name
- MIDODRINE HYDROCHLORIDE
- Active ingredients
- MIDODRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVUGEN
- Manufacturer
- Novugen Pharma (USA) LLC
- First approval
- 2023-10-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown